The future
we work towards.
To be a leading national platform advancing health economics, health outcomes research, and value-based health assessment in Kuwait.
Vision, Mission & Goals
The founding principles and objectives that guide the society’s contribution to better health decisions in Kuwait.
To be a leading national platform advancing health economics, health outcomes research, and value-based health assessment in Kuwait.
To bring together professionals across disciplines to build capabilities, advance research, and support evidence- and value-informed health and pharmaceutical decisions in Kuwait.
English adaptations of our founding principles. The Arabic bylaws are the governing text. Read Article 5
Our goals
The society’s scientific and professional objectives are set out in Article 6 of our bylaws.
Read the governing textAdvance awareness of health economics, pharmacoeconomics and health outcomes research.
Support training in economic evaluation, budget impact analysis, outcomes research and health technology assessment.
Encourage scientific research and academic publication in health economics and health and pharmaceutical policy.
Develop expertise in efficient health spending, value assessment, pricing, reimbursement, access, formulary management and value-based purchasing.
Create a space for scientific and professional dialogue among health professionals, economists, researchers, policymakers and health organizations.
Provide scientific input to initiatives in health assessment, health and pharmaceutical policy, public health and effective use of resources.
Organize workshops, lectures, conferences, seminars and training programs in the society’s fields of work.
Support economic evaluation tools and methods, including cost-effectiveness analysis, budget impact analysis and real-world research.
Promote health data and real-world evidence to inform health and pharmaceutical decisions.
Develop scientific and professional collaboration with relevant organizations in Kuwait, the region and internationally.
Advance pharmacists’ contribution within multidisciplinary work on health economics, pharmaceutical policy, outcomes, supply chains and value-informed decisions.